Interstitial Cystitis (IC), also known as Painful Bladder Syndrome, is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It is a chronic condition that causes painful urinary symptoms. According to the Interstitial Cystitis Association, currently, there are two recognized subtypes of Interstitial cystitis: Nonulcerative and Ulcerative.
&nbsp;
The symptoms include pain in the pelvis or between the vagina and anus in women, and between the scrotum and anus in men (perineum), along with chronic pelvic pain, a persistent, urgent need to urinate, frequent urination&mdash;often of small amounts&mdash;throughout the day and night, pain or discomfort while the bladder fills, and relief after urinating.&nbsp;
&nbsp;
Interstitial Cystitis Epidemiological Segmentation&nbsp;
The Epidemiological Segmentation of Interstitial Cystitis in 7MM from 2017 to 2030 is segmented as:-&nbsp;
<ul>
<li>Total Prevalent Population of Interstitial Cystitis</li>
<li>Total Diagnosed Prevalent Population of Interstitial Cystitis</li>
<li>Gender-specific Prevalent Population of Interstitial Cystitis</li>
<li>Severity-based Diagnosed Prevalent Population of Interstitial Cystitis</li>
<li>Type-specific Diagnosed Prevalent Population of Interstitial Cystitis</li>
<li>Age-specific Diagnosed Prevalent Population of Interstitial Cystitis</li>
</ul>
&nbsp;
<a style="color: #0047b2; background-color: transparent;" href="https://www.delveinsight.com/report-store/interstitial-cystitis-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Interstitial Cystitis Epidemiology</a>&nbsp;
<ul>
<li>The total diagnosed prevalent population of Interstitial Cystitis in the 7 MM in 2017 was 2,264,118</li>
<li>The diagnosed prevalent cases of Interstitial Cystitis patients in the United States in 2017 was 1,459,502</li>
</ul>
&nbsp;
<a style="color: #0047b2; background-color: transparent;" href="https://www.delveinsight.com/report-store/interstitial-cystitis-market" target="_blank" rel="noopener noreferrer">Interstitial Cystitis Market</a>
The market size of Interstitial Cystitis in the 7MM in 2017 was USD 1,599 Million
&nbsp;
Interstitial Cystitis Market Drivers
<ul>
<li>FDA approved Oral medication</li>
<li>Increasing emerging therapies</li>
<li>Increasing awareness</li>
</ul>
&nbsp;
Interstitial Cystitis Market Barriers
<ul>
<li>Lack of Consensus Definition</li>
<li>Intermittent Pipeline Activity</li>
<li>Absence of Validated Biomarkers</li>
</ul>
&nbsp;
<a style="color: #0047b2; background-color: transparent;" href="https://www.delveinsight.com/report-store/interstitial-cystitis-pipeline-insight" target="_blank" rel="noopener noreferrer">Interstitial Cystitis Emerging Drugs</a>
The emerging drugs of the Interstitial Cystitis market are&nbsp;
<ul>
<li>KRP-116D</li>
<li>Certolizumab pegol (Cimzia)</li>
<li>LP-08</li>
<li>GRT6010</li>
<li>ASP6294</li>
<li>SI-722</li>
</ul>
&nbsp;
And many others.&nbsp;&nbsp;
&nbsp;
Interstitial Cystitis Key Players
The key players in the Interstitial Cystitis market are
<ul>
<li>Kyorin Pharmaceutical</li>
<li>UCB Pharma</li>
<li>Lipella Pharmaceuticals</li>
<li>Gr&uuml;nenthal</li>
<li>Astellas Pharma</li>
<li>Seikagaku Corporation</li>
</ul>
And many others.&nbsp;
&nbsp;
Map the recent updates on the <a style="background-color: transparent; color: #0047b2;" href="https://www.delveinsight.com/blog/interstitial-cystitis-market" target="_blank" rel="noopener noreferrer">Interstitial Cystitis treatment market</a> through our latest blog

Interstitial Cystitis Market

Interstitial Cystitis Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.